Re-examining treatment of latent tuberculosis infection.
作者信息
Lynn Johnston B, Conly J M
机构信息
Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia;
出版信息
Can J Infect Dis. 2001 Jul;12(4):211-4. doi: 10.1155/2001/616419.
Abstract
摘要
相似文献
1
Re-examining treatment of latent tuberculosis infection.重新审视潜伏性结核感染的治疗。
Can J Infect Dis. 2001 Jul;12(4):211-4. doi: 10.1155/2001/616419.
2
[Efficacy of the treatment for latent tuberculosis infection and delayed reactivation of tuberculosis].
Kekkaku. 2013 Sep;88(9):667-70.
3
[Novel biomarkers for latent tuberculosis infection by plasma proteomic profiling].[通过血浆蛋白质组学分析鉴定潜伏性结核感染的新型生物标志物]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Jul;39(7):519-23. doi: 10.3760/cma.j.issn.1001-0939.2016.07.006.
4
Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.加拿大新移民登陆后潜伏性结核感染控制策略的成本效益
PLoS One. 2017 Oct 30;12(10):e0186778. doi: 10.1371/journal.pone.0186778. eCollection 2017.
5
[A guinea pig model of latent Mycobacterium tuberculosis H₃₇Rv infection].[结核分枝杆菌H₃₇Rv潜伏感染的豚鼠模型]
Zhonghua Jie He He Hu Xi Za Zhi. 2010 Sep;33(9):684-7.
6
Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study.中国农村人群潜伏结核感染人群中活动性结核病的发病情况：一项基于人群、多中心、前瞻性队列研究的随访结果。
Lancet Infect Dis. 2017 Oct;17(10):1053-1061. doi: 10.1016/S1473-3099(17)30402-4. Epub 2017 Jul 14.
7
Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.2型糖尿病合并潜伏性结核分枝杆菌感染个体中，结核分枝杆菌诱导的CD8+T细胞细胞因子表达受损但细胞毒性标志物表达增强。
J Infect Dis. 2016 Mar 1;213(5):866-70. doi: 10.1093/infdis/jiv484. Epub 2015 Oct 20.
8
Establishment of a guinea pig model of latent tuberculosis with GFP-introduced Mycobacterium tuberculosis.建立携带 GFP 的结核分枝杆菌的豚鼠潜伏结核模型。
Tohoku J Exp Med. 2009 Nov;219(3):257-62. doi: 10.1620/tjem.219.257.
9
The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.潜伏性结核感染诊断和治疗中的诊疗链：系统评价和荟萃分析。
Lancet Infect Dis. 2016 Nov;16(11):1269-1278. doi: 10.1016/S1473-3099(16)30216-X. Epub 2016 Aug 10.
10
Tuberculosis and latent tuberculosis infection among healthcare workers in Kisumu, Kenya.肯尼亚基苏木医护人员中的结核病和潜伏性结核感染
Trop Med Int Health. 2015 Dec;20(12):1797-804. doi: 10.1111/tmi.12601. Epub 2015 Oct 12.
引用本文的文献
1
Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.在高传播环境中，潜伏性结核感染治疗后，γ干扰素水平会升高。
Pulm Med. 2012;2012:757152. doi: 10.1155/2012/757152. Epub 2012 Dec 17.
本文引用的文献
1
Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.对加拿大的移民和难民进行结核病筛查与治疗：加拿大及其他工业化国家经验的启示
Can J Infect Dis. 1995 Sep;6(5):246-55. doi: 10.1155/1995/271936.
2
Preventive effects of isoniazid in the treatment of primary tuberculosis in children.异烟肼在儿童原发性肺结核治疗中的预防作用
N Engl J Med. 1961 Oct 12;265:713-21. doi: 10.1056/NEJM196110122651501.
3
A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.精神病院中异烟肼预防治疗的对照试验。
Am Rev Respir Dis. 1963 Aug;88:161-75. doi: 10.1164/arrd.1963.88.2.161.
4
Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.异烟肼预防性用药在家庭接触者中进行的对照试验中的结核病发病率
Am Rev Respir Dis. 1962 Apr;85:490-510. doi: 10.1164/arrd.1962.85.4.490.
5
Practice guidelines for the treatment of tuberculosis.结核病治疗实践指南。
Clin Infect Dis. 2000 Sep;31(3):633-9. doi: 10.1086/314007. Epub 2000 Oct 4.
6
Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains Aborigines.
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):989-93. doi: 10.1164/ajrccm.162.3.9804117.
7
Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.潜伏性结核感染的治疗：结核病控制的新机遇
Clin Infect Dis. 2000 Jul;31(1):120-4. doi: 10.1086/313891. Epub 2000 Jul 25.
8
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.潜伏性结核感染的靶向结核菌素检测与治疗。本美国胸科学会官方声明于1999年7月由ATS董事会通过。这是美国胸科学会（ATS）与疾病控制和预防中心（CDC）的联合声明。本声明于1999年9月得到美国传染病学会（IDSA）理事会的认可，以及本声明的各章节。
Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47. doi: 10.1164/ajrccm.161.supplement_3.ats600.
9
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.利福平与吡嗪酰胺对比异烟肼用于预防HIV感染者结核病：一项国际随机试验。艾滋病临床研究特里·贝恩社区项目、成人艾滋病临床试验组、泛美卫生组织及疾病控制与预防中心研究小组。
JAMA. 2000 Mar 15;283(11):1445-50. doi: 10.1001/jama.283.11.1445.
Zotero 插件